More Articles on

Tagged Articles

September 10, 2024

Medical Insights on Cannabis and Alcohol Use During Pregnancy

Jeffrey Quinlan, MD, FAAFP, a family physician & academic leader, discusses the rising concerns about cannabis use during pregnancy, elaborating on the significance of preconception counseling, the risks associated with substance use during pregnancy, & advocates for open communication between physicians and patients.

September 09, 2024

September is FASD Awareness Month

FASD is a spectrum disorder and describes a range of diagnosable conditions that can occur with prenatal alcohol exposure (PAE). As many as 1 in 20 Americans may be living with FASD.

August 13, 2024

Immunization: Protect Your Patients

During National Immunization Awareness Month, help increase your patients’ vaccination rates by recommending vaccines and how to access them.

July 22, 2024

EQIP PC Program Request for Applications is now open

EQIP is a voluntary program that will provide incentive payments to practitioners who improve the quality of care and reduce the cost of care that they provide to Maryland Medicare patient

July 12, 2024

AAFP issues statement on 2025 Proposed Medicare Physician Fee Schedule

The CY 2025 Medicare Physician Fee Schedule and Quality Payment Program proposed rule was released earlier this week. AAFP has issued a statement.

May 23, 2024

Meningococcal Disease Cases Linked to Travel to the Kingdom of Saudi Arabia

Learn how you can protect your traveling patients

March 21, 2024

Call for Resolutions to AAFP COD

Deadline: July 1, 2024

March 11, 2024

Opioid Use Disorder: Medicare Pays for Certain Treatment Services

Medicare pays for opioid use disorder (OUD) screenings performed by physicians and non-physician practitioners.

March 07, 2024

Opioid Use Disorder: Medicare Pays for Certain Treatment Services

Medicare pays for opioid use disorder (OUD) screenings performed by physicians and non-physician practitioners.

December 13, 2023

Maryland Medicaid’s Preferred Drug List (PDL)

Tune in to updates to the Maryland Medicaid’s Preferred Drug List (PDL) and Brand Preferred over Generic Program, effective January 1, 2024.

June 26, 2023

MATE Act Training Resources

The training requirement is for prescribers of controlled substances in schedules II, III, IV, and V to complete a one-time, eight-hour training prior to their first registration or renewal of their DEA license.